KIR3DL3 as an HHLA2 receptor, anti-HHLA2 antibodies, and uses thereof

• 收藏
• 分享

专利权人:

Dana-Farber Cancer Institute; Inc.

发明人:

FREEMAN, Gordon J.,ARULANANDAM, Antonio R.

申请号：

AU2019257249

公开号：

AU2019257249A1

申请日:

2019.04.05

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The present invention is based, in part, on the discovery of monoclonal antibodies, and antigen-binding fragments thereof, that specifically bind to HHLA2, as well as immunoglobulins, polypeptides, nucleic acids thereof, and methods of using such antibodies for diagnostic, prognostic, and therapeutic purposes.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/